Title : Inhibition of cFLIP overcomes acquired resistance to sorafenib via reducing ER stress‑related autophagy in hepatocellular carcinoma.

Pub. Date : 2018 Oct

PMID : 30066934






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Inhibition of cFLIP overcomes acquired resistance to sorafenib via reducing ER stress-related autophagy in hepatocellular carcinoma. Sorafenib CASP8 and FADD like apoptosis regulator Homo sapiens
2 The knockdown of cFLIP reversed the acquired sorafenib resistance by activating caspase-8 and inhibiting activated ERS in the sorafenib-resistant HCC cells. Sorafenib CASP8 and FADD like apoptosis regulator Homo sapiens
3 The knockdown of cFLIP reversed the acquired sorafenib resistance by activating caspase-8 and inhibiting activated ERS in the sorafenib-resistant HCC cells. Sorafenib CASP8 and FADD like apoptosis regulator Homo sapiens
4 In conclusion, cFLIP was identified as a potential target for overcoming the acquired sorafenib resistance in HCC. Sorafenib CASP8 and FADD like apoptosis regulator Homo sapiens